Alphaxalone inhibits growth, migration and invasion of rat C6 malignant glioma cells. 2013

Huawei Sun, and Xiaoke Zheng, and Yuehan Zhou, and Wenbo Zhu, and Yanqiu Ou, and Minfeng Shu, and Xiuren Gao, and Tiandong Leng, and Pengxin Qiu, and Guangmei Yan
Department of Cardiology, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China.

Malignant gliomas are the most devastating and aggressive brain tumors affecting the central nervous system. The insidious growth and infiltration are the most prominent characteristics of malignant gliomas, which render the current therapies for malignant gliomas including surgery, radiation and chemotherapy unsuccessful. Inhibition of infiltration as well as proliferation in combination with surgery might be more effective in the treatment of malignant gliomas. In the current study, we demonstrate the alphaxalone (3-hydroxypregnane-11,20-dione) could effectively inhibit the proliferation of C6 glioma cells in a concentration dependent manner. Moreover, this compound could also suppress the migration and invasion of C6 glioma cells at a concentration without causing significant cytotoxicity. Except the in vitro anti-glioma activity, alphaxalone effectively delayed the growth of rat C6 malignant glioma xenografts in vivo. Together, these findings suggest alphaxalone might be a promising candidate for the treatment of malignant gliomas and may also provide helpful clues for anti-glioma drugs development in future.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D011277 Pregnanediones Pregnane derivatives in which two side-chain methyl groups or two methylene groups in the ring skeleton (or a combination thereof) have been oxidized to keto groups. Diketopregnanes,Dioxopregnanes
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005260 Female Females
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Huawei Sun, and Xiaoke Zheng, and Yuehan Zhou, and Wenbo Zhu, and Yanqiu Ou, and Minfeng Shu, and Xiuren Gao, and Tiandong Leng, and Pengxin Qiu, and Guangmei Yan
February 2007, Journal of neuro-oncology,
Huawei Sun, and Xiaoke Zheng, and Yuehan Zhou, and Wenbo Zhu, and Yanqiu Ou, and Minfeng Shu, and Xiuren Gao, and Tiandong Leng, and Pengxin Qiu, and Guangmei Yan
January 2015, International journal of clinical and experimental medicine,
Huawei Sun, and Xiaoke Zheng, and Yuehan Zhou, and Wenbo Zhu, and Yanqiu Ou, and Minfeng Shu, and Xiuren Gao, and Tiandong Leng, and Pengxin Qiu, and Guangmei Yan
March 2015, CNS neuroscience & therapeutics,
Huawei Sun, and Xiaoke Zheng, and Yuehan Zhou, and Wenbo Zhu, and Yanqiu Ou, and Minfeng Shu, and Xiuren Gao, and Tiandong Leng, and Pengxin Qiu, and Guangmei Yan
June 2019, Cell biochemistry and function,
Huawei Sun, and Xiaoke Zheng, and Yuehan Zhou, and Wenbo Zhu, and Yanqiu Ou, and Minfeng Shu, and Xiuren Gao, and Tiandong Leng, and Pengxin Qiu, and Guangmei Yan
June 2016, Oncology reports,
Huawei Sun, and Xiaoke Zheng, and Yuehan Zhou, and Wenbo Zhu, and Yanqiu Ou, and Minfeng Shu, and Xiuren Gao, and Tiandong Leng, and Pengxin Qiu, and Guangmei Yan
March 2018, Molecular cancer therapeutics,
Huawei Sun, and Xiaoke Zheng, and Yuehan Zhou, and Wenbo Zhu, and Yanqiu Ou, and Minfeng Shu, and Xiuren Gao, and Tiandong Leng, and Pengxin Qiu, and Guangmei Yan
April 1990, Neurosurgery,
Huawei Sun, and Xiaoke Zheng, and Yuehan Zhou, and Wenbo Zhu, and Yanqiu Ou, and Minfeng Shu, and Xiuren Gao, and Tiandong Leng, and Pengxin Qiu, and Guangmei Yan
August 2012, Journal of neuro-oncology,
Huawei Sun, and Xiaoke Zheng, and Yuehan Zhou, and Wenbo Zhu, and Yanqiu Ou, and Minfeng Shu, and Xiuren Gao, and Tiandong Leng, and Pengxin Qiu, and Guangmei Yan
June 2013, Biotechnology letters,
Huawei Sun, and Xiaoke Zheng, and Yuehan Zhou, and Wenbo Zhu, and Yanqiu Ou, and Minfeng Shu, and Xiuren Gao, and Tiandong Leng, and Pengxin Qiu, and Guangmei Yan
August 2009, International journal of cancer,
Copied contents to your clipboard!